학술논문
MM-163 Long-Term Follow-Up From MajesTEC-1 of Teclistamab, a B-Cell Maturation Antigen (BCMA) × CD3 Bispecific Antibody, in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Document Type
Abstract
Author
van de Donk, Niels; Moreau, Philippe; Garfall, Alfred; Bhutani, Manisha; Oriol, Albert; Nooka, Ajay; Martin, Thomas; Rosinol, Laura; Mateos, Maria-Victoria; Bahlis, Nizar; Popat, Rakesh; Besemer, Britta; Lopez, Joaquin Martinez; Krishnan, Amrita; Delforge, Michel; Trancucci, Danielle; Verona, Raluca; Stephenson, Tara; Chastain, Katherine; Sidana, Surbhi
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S477-S478
Subject
Language
ISSN
2152-2650